FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TYGACIL (tigecycline) by Wyeth Pharmaceuticals (a Pfizer subsidiary), indicating regulatory approval of a modifi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Complicated Intra-abdominal Infections
• Complicated Skin and Skin Structure Infections

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

SUPPL AP for TYGACIL (TIGECYCLINE)